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INTRODUCTION 
Refractive error after corneal transplantation (PK) can limit 
visual rehabilitation [1, 2]. Excimer laser techniques, 
specifically photorefractive keratectomy (PRK), laser in situ 
keratomileusis (LASIK) and laser assisted subepithelial 
keratectomy (LASEK), have proven effective in correcting 
post-keratoplasty astigmatism [3]. LASEK has demonstrated 
faster rehabilitation and less pain compared to PRK, and no 
stromal flap complications as compared to LASIK, and is 
often the treatment of choice post-PK [4, 5]. Laser procedures 
often result in corneal opacity, or ‘haze’, which can 
compromise corneal transparency and surface regularity [6].
 
Recently, the anti-proliferative drug mitomycin-C has been 
used intraoperatively to prevent haze formation. To date, there 
are no studies assessing the effectiveness of MMC in 
refractive surgery-induced haze post-PK.The purpose of this 
study was to investigate visual outcomes and haze formation 
following LASEK surgery with and without the intraoperative 
use of MMC in PK patients. 
METHODS 
This retrospective analysis reviewed the outcomes of patients 
who had PK and subsequent excimer laser refractive 
procedure in a nonhospital surgical facility with follow-up in a 
private practice in Calgary, Alberta. This study comprised 95 
eyes of 84 patients. The mean patient age at treatment was 56 
years. There were 50 patients (58 eyes) who received LASEK 
without MMC (NOMMC) and 34 patients (37 eyes) who 
received LASEK with MMC (MMC). 
RESULTS 
At last follow-up (average 11.48 months post-op), the mean 
spherical equivalence (SE) decreased from -2.84 D ± 3.98 to -
0.41 D ± 3.41 in the NOMMC group and -2.19 D ± 4.85 to -
0.40 D ± 1.88 in the MMC group. Preoperative uncorrected 
distance visual acuity (UDVA) was 1.56 ± 0.57 (n = 57) and 
1.27 ± 0.55 (n = 28), respectively and postoperative UDVA, 
0.91 ± 0.58 (n = 57) and 0.81 ± 0.53 (n = 33). SE and UDVA 
improved significantly for both groups, p < .01. There was no 
significant difference in SE or UDVA between groups at last 
follow-up, p > .05. 15 patients in the NOMMC group and no 
patients in the MMC group required post-operative treatment 
for haze. 23 and 4 required laser enhancement treatment, 
respectively. As seen in Figure 1, there was a significant 
difference between post-operative haze (0 to 3 scale) at last 
follow-up in the NOMMC group ( M = 0.64, SD = 0.86), and 





Figure 1. Post-operative haze at different times of follow-up. 
DISCUSSION AND CONCLUSIONS 
The significant difference in SE and UDVA pre- to post-
operatively for both groups suggests that LASEK with or 
without mitomycin-C is a viable and successful treatment 
solution to myopia and astigmatism post-PK. The significant 
difference in post-operative haze at last follow-up between the 
two groups suggests that LASEK with MMC post-PK may 
effectively reduce the incidence of haze as compared to 
LASEK without. Larger, prospective randomized trials are 
needed to further assess the efficiency of MMC in reducing 
laser induced haze following corneal transplantation.  
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